Prevalence of blaCTX-M, blaTEM, and blaSHV Genes among Extended-spectrum ????-lactamases-producing Clinical Isolates of Enterobacteriaceae in Different Regions of Sudan
DOI:
https://doi.org/10.52981/sjms.v16i1.1093Keywords:
phenotypic,, blaCTX-M, blaTEM, blaSHV ESBLs genes, Enterobacteriaceae, SudanAbstract
Background: This study aimed to characterize blaCTX-M, blaTEM, and blaSHV genes among extended-spectrum beta-lactamases (ESBLs)-producing Enterobacteriaceae species in different regions of Sudan.
Methods: In this cross-sectional study, different clinical samples (n = 985) were collected randomly from symptomatic patients from four geographical regions of Sudan and cultured on chromogenic media. Following bacterial identification, phenotypic screening of ESBLs was done according to CLSI guidelines using cefotaxime (30 ?g), ceftazidime (30 ?g), and cefepime (30 ?g) discs with and without clavulanic acid. The DNA was extracted by guanidine hydrochloride protocol, and then conventional PCR was used to detect blaCTX-M, blaTEM, and blaSHV genes. The presence of genes’ subtypes was characterized by DNA Sanger sequencing for selected samples.
Results: Enterobacteriaceae represented 31% (305/985) of all isolates, 42 (128/305) of which were ESBLs producer, confirmed by phenotypic confirmatory test (75% [96/128] of them were positive for blaCTX-M genes, 61% [78/128] for blaTEM genes, and 38% [48/128] for blaSHV genes). Fourteen isolates (11%) were negative for all genes. Forty-eight percent (63/75) of Escherichia coli isolates were positive for blaCTX-M, while in Klebsiella pneumoniae, the dominant gene was blaTEM (82%) and had a low amount of blaSHV (59%). There was a significant association (P-value = 0.001 for all except for chloramphenicol, P = 0.014, and amikacin, P = 0.017) between resistance to third-generation cephalosporins and ciprofloxacin, nalidixic acid, meropenem, chloramphenicol, and amikacin. Forty-two percent (40/96) of CTX-M-positive isolates were in Gizera State, 33% (32.96) in Sinnar, 24% (23/96) in Khartoum, and 1% (1/96) in White Nile.
Conclusion: We conclude that blaCTX-M genes are the most dominant genes in ESBLsproducing isolates and are more prevalent in big cities than in rural areas.
References
[2] Rodrigo-Troyano, A. and Sibila, O. (2017). The respiratory threat posed by multidrugresistantGram-negative bacteria. Respirology, vol. 22, no. 7, pp. 1288–1299.
[3] Mohajeri, P., Kavosi, S., Esmailzadeh, T., et al. (2018). Molecular characteristicsof extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates inthe West of Iran. Advances in Human Biology, vol. 8, no. 3, p. 175.
[4] Chong, Y., Shimoda, S., and Shimono, N. (2018). Current epidemiology, genetic evolutionand clinical impact of extended-spectrum ?-lactamase-producing Escherichiacoli and Klebsiella pneumoniae. Infection, Genetics and Evolution, vol. 61, pp. 185–188.
[5] Munday, C., Whitehead, G., Todd, N., et al. (2004). Predominance and genetic diversityof community-and hospital-acquired CTX-M extended-spectrum ?-lactamases inYork, UK. Journal of Antimicrobial Chemotherapy, vol. 54, no. 3, pp. 628–633.
[6] Awad, A., Eltayeb, I., Matowe, L., et al. (2005). Self-medication with antibiotics andantimalarials in the community of Khartoum State, Sudan. Journal of Pharmacy &Pharmaceutical Sciences, vol. 8, no. 2, pp. 326–331.
[7] Sherif, F. M. (2008). An evaluation of the prescribing patterns of rugs in Libya. JMJ,vol. 8, no. 3, pp. 203–206.
[8] Sirdar, M. M., Picard, J., Bisschop, S., et al. (2012). A survey of antimicrobial residuesin table eggs in Khartoum State, Sudan, 2007-2008. Onderstepoort Journal ofVeterinary Research, vol. 79, no. 1, pp. 01–09.
[9] Altayb, H. N., Siddig, M. A., El Amin, N. M., et al. (2018). Molecular characterization ofCTX-M ESBLs among pathogenic Enterobacteriaceae isolated from different regionsin Sudan. Global Advanced Research Journal of Microbiology,vol.7,no.2,pp.040–047.
[10] Ahmed, A. M., Mohammed, H., Mohammed, S. A. S., et al. (2019). CTX-M ?-lactamaseproducingEscherichia coli in SUDAN tertiary hospitals: detection genotypes variantsand bioinformatics analysis. International Journal of Medical and BiomedicalStudies, vol. 3, no. 3.
[11] Musa, H. A., Osman, M. A., Abdelaziz, Y. H., et al. (2019). Distribution of extendedspectrumbeta-lactamase TEM and CTX-M resistance genes among Proteus speciesisolated in Sudan. VacciMonitor, vol. 28, no. 2, pp. 80–84.
[12] Kassim, A., Omuse, G., Premji, Z., et al. (2016). Comparison of Clinical LaboratoryStandards Institute and European Committee on Antimicrobial Susceptibility Testingguidelines for the interpretation of antibiotic susceptibility at a University TeachingHospital in Nairobi, Kenya: a cross-sectional study. Annals of Clinical Microbiologyand Antimicrobials, vol. 15, no. 1, p. 21.
[13] Clinical Lab Standards Institute (CLSI). (2016). Performance Standards ForAntimicrobial Susceptibility Testing. CLSI.
[14] Sabeel, S., Salih, M. A., Ali, M., et al. (2017). Phenotypic and genotypic analysisof multidrug-resistant Mycobacterium tuberculosis isolates from Sudanese patients.Tuberculosis Research and Treatment 2017, vol. 2017, p. 8340746.
[15] Cao, V., Lambert, T., and Courvalin, P. (2002). ColE1-like plasmid pIP843 of Klebsiellapneumoniae encoding extended-spectrum ?-lactamase CTX-M-17. AntimicrobialAgents and Chemotherapy, vol. 46, no. 5, pp. 1212–1217.
[16] Siddaramappa, S., Pullela, K., Thimmappa, B., et al. (2018). Characterization ofblaCTX-M sequences of Indian origin and thirteen uropathogenic Escherichia coliisolates resistant to multiple antibiotics. BMC Research Notes, vol. 11, no. 1, p. 630.
[17] Canton, R. and Coque, T. M. (2006). The CTX-M beta-lactamase pandemic. CurrentOpinion in Microbiology, vol. 9, no. 5, pp. 466–475.
[18] Copur Cicek, A., Saral, A., Ozad Duzgun, A., et al. (2013). Nationwide study ofEscherichia coli producing extended-spectrum beta-lactamases TEM, SHV and CTXMin Turkey. The Journal of Antibiotics, vol. 66, no. 11, pp. 647–650.
[19] Mekki, A. H., Hassan, A. N., and Elsayed, D. E. M. (2010). Extended spectrum betalactamases among multi drug resistant Escherichia coli and Klebsiella speciescausing urinary tract infections in Khartoum. African Journal of BacteriologyResearch, vol. 2, no. 3, pp. 18–21.
[20] Ahmed, O. B., Omar, A. O., Asghar, A. H., et al. (2013). Prevalence of TEM, SHV andCTX-M genes in Escherichia coli and Klebsiella spp urinary isolates from Sudan withconfirmed ESBL phenotype. Life Science Journal, vol. 10, no, 2, pp. 191–195.
[21] Hamedelnil, F. and Eltayeb, H. (2012). Molecular detection of extended spectrum ?-lactamases (ESBLs) genes in E. coli isolated from urine specimens. InternationalJournal of Advanced Scientific Research. amedelnil, F. and Eltayeb, H. (2012).Molecular detection of extended spectrum ?-lactamases (ESBLs) genes in E.coli isolated from urine specimens. International Journal of Advanced ScientificResearch .vol. 5, no. 5, pp. 407-417.
[22] Poirel, L., Naas, T., Le Thomas, I., et al. (2001). CTX-M-type extended-spectrum ?-lactamase that hydrolyzes ceftazidime through a single amino acid substitution inthe omega loop. Antimicrobial Agents and Chemotherapy, vol. 45, no. 12, pp. 3355–3361.
[23] Bae, I. K., Lee, B. H., Hwang, H. Y., et al. (2006). A novel ceftazidime-hydrolysingextended-spectrum ?-lactamase, CTX-M-54, with a single amino acid substitution atposition 167 in the omega loop. Journal of Antimicrobial Chemotherapy, vol. 58, no.2, pp. 315–319.
[24] Lautenbach, E., Patel, J. B., Bilker, W. B., et al. (2001). Extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors forinfection and impact of resistance on outcomes. Clinical Infectious Diseases, vol.32, no. 8, pp. 1162–1171.
[25] Feizabadi, M. M., Mahamadi-Yeganeh, S., Mirsalehian, A., et al. (2010). Geneticcharacterization of ESBL producing strains of Klebsiella pneumoniae from Tehranhospitals. The Journal of Infection in Developing Countries, vol. 4, no. 10, pp. 609–615.
[26] Kiratisin, P., Apisarnthanarak, A., Laesripa, C., et al. (2008). Molecular characterizationand epidemiology of extended-spectrum-?-lactamase-producing Escherichia coliand Klebsiella pneumoniae isolates causing health care-associated infectionin Thailand, where the CTX-M family is endemic. Antimicrobial Agents andChemotherapy, vol. 52, no. 8, pp. 2818–2824.
[27] Bauernfeind, A., Stemplinger, I., Jungwirth, R., et al. (1996). Characterization of betalactamasegene blaPER-2, which encodes an extended-spectrum class A betalactamase.Antimicrobial Agents and Chemotherapy, vol. 40, no. 3, pp. 616–620.